Medindia
Medindia LOGIN REGISTER
Advertisement

ChemPartner Receives 2009 Most Valuable Partner (MVP) Award from Roche R&D Center China (RRDCC)

Saturday, February 6, 2010 Press Release
Advertisement
SHANGHAI, Feb. 5 Shanghai ChemPartner, a leadingChina-based contract research organization and a wholly owned subsidiary ofShangPharma, today announced that it had received the 2009 Most ValuablePartner (MVP) Award from Roche R&D Center China (RRDCC) for excellent serviceand outstanding contributions in the area of Oncology and DiabetesPharmacology research, which have successfully helped advance the RRDCC drugdiscovery project milestones during 2009.
Advertisement

"We are very pleased with the collaboration with ChemPartner on biologyresearch. Our R&D success today would be impossible without the excellent workof collaboration partners like you," Dr. Li Chen, CSO of RRDCC, commented atthe award ceremony. "We are riding the same boat. Our collaboration iscreating a new model of drug discovery in China."
Advertisement

"We are honored to receive this award and appreciate Roche China'srecognition of the efforts and dedication of our talented team of scientists.This award reflects the value and capabilities of ChemPartner's service to ourpartners," commented Michael Hui, founder and CEO of ChemPartner.

"We will continue to focus on the quality of our science, projectmanagement and logistics, to add value for our partners R&D programs," Dr.Yuguang Wang, Senior VP of ChemPartner added. "We are also committed toprovide intellectual contributions to our customers and partners by leveragingthe R&D expertise of our scientific team."

RRDCC MVP awards are presented annually to partners who have doneexcellent work in collaboration with RRDCC. More than 20 external partnerswere evaluated in this award competition of 2009.

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leadingcontract research organizations providing medicinal chemistry, discoverybiology, pharmacology, DMPK, toxicology, process R&D, analytical development,formulation and contract manufacturing services to over 120 pharmaceutical andbiotech companies in the world. ChemPartner currently has a team of over 1,000scientists including more than 100 senior scientific leaders with extensiveindustry experiences gained from leading global pharmaceutical and biotechcompanies. Headquartered in China, ChemPartner has overseas businessdevelopment operations in Boston, USA and Copenhagen, Denmark.

About ShangPharma

ShangPharma is a leading China-based outsourcing partner in pharmaceuticaland biotechnology research and development, who provides customized servicesto international pharmaceutical, biotech, agrochemical and chemical companies.As the holding company of Shanghai ChemPartner Co., Ltd., ShanghaiChemExplorer Company Ltd., China Gateway Pharmaceutical (Shanghai) Ltd. andChina Gateway Pharma Products (Chengdu) Ltd., ShangPharma offers globalpharmaceutical, biotechnology and chemical companies comprehensive servicesand materials for their research and development needs. ShangPharma currentlyhas a team of more than 1,800 professionals, and more than 60% of theemployees have post graduate educational experience of Master or Ph.D. degrees.ShangPharma has established comprehensive R&D partnerships with world-classacademic institutes, universities as well as healthcare industry andorganizations, to contribute more added-value for its clients' success.Further information is available at http://www.shangpharma.com. For more information, please contact: Media Contacts: Ms. Jasmine Luo Public Affairs Department Shanghai ChemPartner Tel: +86-21-5137-0655 Email: [email protected]

SOURCE Shanghai ChemPartner
Sponsored Post and Backlink Submission


This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close